{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:59:09Z","timestamp":1697457549662},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,29]],"date-time":"2009-11-29T00:00:00Z","timestamp":1259452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11894-009-0074-7","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T05:59:14Z","timestamp":1259387954000},"page":"488-495","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic advances in inflammatory bowel disease (imaging and laboratory)"],"prefix":"10.1007","volume":"11","author":[{"given":"Maria E.","family":"Moscandrew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,29]]},"reference":[{"key":"74_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJM199109263251306","volume":"325","author":"D.K. Podolsky","year":"1991","unstructured":"Podolsky DK: Inflammatory bowel disease (1). N Engl J Med 1991, 325:928\u2013937.","journal-title":"N Engl J Med"},{"key":"74_CR2","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19SupplA","author":"M.S. Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5A\u201336A.","journal-title":"Can J Gastroenterol"},{"key":"74_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"D.C. Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627\u20131640.","journal-title":"Lancet"},{"key":"74_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.gtc.2008.03.001","volume":"37","author":"S. Vermeire","year":"2008","unstructured":"Vermeire S, Vermeulen N, Van Assche G, et al.: (Auto)antibodies in inflammatory bowel diseases. Gastroenterol Clin North Am 2008, 37:429\u2013438.","journal-title":"Gastroenterol Clin North Am"},{"key":"74_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2006.02.003","volume":"130","author":"N. Gupta","year":"2006","unstructured":"Gupta N, Cohen SA, Bostrom AG, et al.: Risk factors for initial surgery in pediatric patients with Crohn\u2019s disease. Gastroenterology 2006, 130:1069\u20131077.","journal-title":"Gastroenterology"},{"key":"74_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ibd.20106","volume":"13","author":"K.A. Papadakis","year":"2007","unstructured":"Papadakis KA, Yang H, Ippoliti A, et al.: Anti-flagellin (CBir1) phenotypic and genetic Crohn\u2019s disease associations. Inflamm Bowel Dis 2007, 13:524\u2013530.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s10875-008-9255-7","volume":"29","author":"S. Ashorn","year":"2009","unstructured":"Ashorn S, Valineva T, Kaukinen K, et al.: Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 2009, 29:190\u2013195.","journal-title":"J Clin Immunol"},{"key":"74_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1440-1746.2005.04027.x","volume":"21","author":"A. Holstein","year":"2006","unstructured":"Holstein A, Burmeister J, Plaschke A, et al.: Autoantibody profiles in microscopic colitis. J Gastroenterol Hepatol 2006, 21:1016\u20131020.","journal-title":"J Gastroenterol Hepatol"},{"key":"74_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2249.2003.02166.x","volume":"132","author":"P. Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Guidi M, et al.: Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003, 132:473\u2013476.","journal-title":"Clin Exp Immunol"},{"key":"74_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s10620-007-0092-y","volume":"53","author":"W. Sakly","year":"2008","unstructured":"Sakly W, Jeddi M, Ghedira I: Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci 2008, 53:1983\u20131987.","journal-title":"Dig Dis Sci"},{"key":"74_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MPG.0b013e31812f7f6e","volume":"45","author":"M.K. Davis","year":"2007","unstructured":"Davis MK, Andres JM, Jolley CD, et al.: Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevesiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 2007, 45:409\u2013413.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"74_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ibd.20831","volume":"15","author":"J. Markowitz","year":"2009","unstructured":"Markowitz J, Kugathasan S, Dubinsky M, et al.: Age of diagnosis influences serologic responses in children with Crohn\u2019s disease: a possible clue to etiology?\n                           Inflamm Bowel Dis 2009, 15:714\u2013719.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.MIB.0000218765.84087.42","volume":"12","author":"S. Iltanen","year":"2006","unstructured":"Iltanen S, Tervo L, Halttunen T, et al.: Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. Inflamm Bowel Dis 2006, 12:389\u2013394.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ibd.20535","volume":"15","author":"S. Ashorn","year":"2009","unstructured":"Ashorn S, Honkanen T, Kolho KL, et al.: Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:199\u2013205.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1572-0241.2007.01648.x","volume":"103","author":"P. Vandewalle-El Khoury","year":"2008","unstructured":"Vandewalle-El Khoury P, Colombel JF, Joossens S, et al.: Detection of antisynthetic mannoside antibodies (AsigmaMA) reveals heterogeneity in the ASCA response of Crohn\u2019s disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol 2008, 103:949\u2013957.","journal-title":"Am J Gastroenterol"},{"key":"74_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","volume":"103","author":"M. Papp","year":"2008","unstructured":"Papp M, Altorjay I, Dotan N, et al.: New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008, 103:665\u2013681.","journal-title":"Am J Gastroenterol"},{"key":"74_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2006.108043","volume":"56","author":"M. Ferrante","year":"2007","unstructured":"Ferrante M, Henckaerts L, Joossens M, et al.: New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007, 56:1394\u20131403.","journal-title":"Gut"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ajg.2009.79","volume":"104","author":"C.H. Seow","year":"2009","unstructured":"Seow CH, Stempak JM, Xu W, et al.: Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am J Gastroenterol 2009, 104:1426\u20131434.","journal-title":"Am J Gastroenterol"},{"key":"74_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1572-0241.2006.00456.x","volume":"101","author":"M.C. Dubinsky","year":"2006","unstructured":"Dubinsky MC, Lin YC, Dutridge D, et al.: Serum immune responses predict rapid disease progression among children with Crohn\u2019s disease: immune responses predict disease progression. Am J Gastroenterol 2006, 101:360\u2013367.","journal-title":"Am J Gastroenterol"},{"key":"74_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1572-0241.2006.00468.x","volume":"101","author":"D.K. Amre","year":"2006","unstructured":"Amre DK, Lu SE, Costea F, et al.: Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn\u2019s disease patients. Am J Gastroenterol 2006, 101:645\u2013652.","journal-title":"Am J Gastroenterol"},{"key":"74_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ibd.20781","volume":"15","author":"I.C. Solberg","year":"2009","unstructured":"Solberg IC, Lygren I, Cvancarova M, et al.: Predictive value of serological markers in a population-based Norwegian cohort with inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:406\u2013414.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cgh.2008.04.032","volume":"6","author":"M.C. Dubinsky","year":"2008","unstructured":"Dubinsky MC, Kugathasan S, Mei L, et al.: Increased immune reactivity predicts aggressive complicating Crohn\u2019s disease in children. Clin Gastroenterol Hepatol 2008, 6:1105\u20131111.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"74_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.crohns.2007.10.001","volume":"2","author":"O. Hoie","year":"2008","unstructured":"Hoie O, Aamodt G, Vermeire S, et al.: Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohn\u2019s Colitis 2008, 2:114\u2013122.","journal-title":"J Crohn\u2019s Colitis"},{"key":"74_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10350-007-9158-3","volume":"51","author":"G.Y. Melmed","year":"2008","unstructured":"Melmed GY, Fleshner PR, Bardakcioglu O, et al.: Family history and serology predict Crohn\u2019s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008, 51:100\u2013108.","journal-title":"Dis Colon Rectum"},{"key":"74_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cgh.2008.01.002","volume":"6","author":"P. Fleshner","year":"2008","unstructured":"Fleshner P, Ippoliti A, Dubinsky M, et al.: Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:561\u2013568.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"74_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.crohns.2007.10.003","volume":"2","author":"M. Ferrante","year":"2008","unstructured":"Ferrante M, Declerck S, Coopmans T, et al.: Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: a role for serological markers and microbial pattern recognition receptor genes. J Crohn\u2019s Colitis 2008, 2:142\u2013151.","journal-title":"J Crohn\u2019s Colitis"},{"key":"74_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S. Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P: Laboratory markers in IBD: useful, magic, or unnecessary toys?\n                           Gut 2006, 55:426\u2013431.","journal-title":"Gut"},{"key":"74_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1515\/CCLM.2009.005","volume":"47","author":"J. Jones","year":"2009","unstructured":"Jones J, Chen LS, Baudhuin L, et al.: Relationships between C-reactive protein concentration and genotype in healthy volunteers. Clin Chem Lab Med 2009, 47:20\u201325.","journal-title":"Clin Chem Lab Med"},{"key":"74_CR29","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","volume":"6","author":"J. Jones","year":"2008","unstructured":"Jones J, Loftus EV, Panaccione R, et al.: Relationships between disease activity and serum and fecal biomarkers in patients with Crohn\u2019s disease. Clin Gastroenterol Hepatol 2008, 6:1218\u20131224.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"74_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.dld.2007.06.015","volume":"39","author":"S. Karoui","year":"2007","unstructured":"Karoui S, Ouerdiane S, Serghini M, et al.: Correlation between levels of C-reactive protein and clinical activity in Crohn\u2019s disease. Dig Liver Dis 2007, 39:1006\u20131010.","journal-title":"Dig Liver Dis"},{"key":"74_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.crohns.2008.05.001","volume":"2","author":"N. Maharshak","year":"2008","unstructured":"Maharshak N, Zilberman L, Arbel Y, et al.: Microin-flammation in patients with Crohn\u2019s disease in clinical remission. J Crohn\u2019s Colitis 2008, 2:310\u2013314.","journal-title":"J Crohn\u2019s Colitis"},{"key":"74_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3748\/wjg.14.85","volume":"14","author":"C.L. Koelewijn","year":"2008","unstructured":"Koelewijn CL, Schwartz MP, Samsom M, et al.: C-reactive protein levels during a relapse of Crohn\u2019s disease are associated with the clinical course of the disease. World J Gastroenterol 2008, 14:85\u201389.","journal-title":"World J Gastroenterol"},{"key":"74_CR33","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/gut.2007.134817","volume":"57","author":"A. Bitton","year":"2008","unstructured":"Bitton A, Dobkin PL, Edwardes MD, et al.: Predicting relapse in Crohn\u2019s disease: a biopsychosocial model. Gut 2008, 57:1386\u20131392.","journal-title":"Gut"},{"key":"74_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1572-0241.2007.01653.x","volume":"103","author":"W. Cacheux","year":"2008","unstructured":"Cacheux W, Seksik P, Lemann M, et al.: Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008, 103:637\u2013642.","journal-title":"Am J Gastroenterol"},{"key":"74_CR35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/gut.2007.146357","volume":"57","author":"M. Henriksen","year":"2008","unstructured":"Henriksen M, Jahnsen J, Lygren I, et al.: C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008, 57:1518\u20131523.","journal-title":"Gut"},{"key":"74_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00365520802600961","volume":"44","author":"I.C. Solberg","year":"2009","unstructured":"Solberg IC, Lygren I, Jahnsen J, et al.: Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009, 44:431\u2013440.","journal-title":"Scand J Gastroenterol"},{"key":"74_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","volume":"102","author":"A.C. Roon von","year":"2007","unstructured":"von Roon AC, Karamountzos L, Purkayastha S, et al.: Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007, 102:803\u2013813.","journal-title":"Am J Gastroenterol"},{"key":"74_CR38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J. Langhorst","year":"2008","unstructured":"Langhorst J, Elsenbruch S, Koelzer J, et al.: Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008, 103:162\u2013169.","journal-title":"Am J Gastroenterol"},{"key":"74_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ibd.20820","volume":"15","author":"M.A. Quaill","year":"2009","unstructured":"Quaill MA, Russell RK, Van Limbergen JE, et al.: Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:756\u2013759.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MPG.0b013e31816533d3","volume":"48","author":"M. Joishy","year":"2009","unstructured":"Joishy M, Davies I, Ahmed M, et al.: Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009, 48:48\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"74_CR41","first-page":"A34","volume":"136Suppl1","author":"A. Schoepfer","year":"2009","unstructured":"Schoepfer A, Beglinger C, Straumann A, et al.: Ulcerative colitis: fecal calprotectin correlates closely with the endoscopically assessed disease activity [abstract]. Gastroenterology 2009, 136 (Suppl 1):A34.","journal-title":"Gastroenterology"},{"key":"74_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","volume":"28","author":"T. Sipponen","year":"2008","unstructured":"Sipponen T, Karkkainen P, Savilahti E, et al.: Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn\u2019s disease and histologic findings. Aliment Pharmacol Ther 2008, 28:1221\u20131229.","journal-title":"Aliment Pharmacol Ther"},{"key":"74_CR43","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/ibd.20490","volume":"14","author":"T. Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, Karkkainen P, et al.: Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn\u2019s disease. Inflamm Bowel Dis 2008, 14:1392\u20131398.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR44","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/ibd.20472","volume":"14","author":"A. Diamanti","year":"2008","unstructured":"Diamanti A, Colistro F, Basso MS, et al.: Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases. Inflamm Bowel Dis 2008, 14:1229\u20131235.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ibd.20376","volume":"14","author":"D. Walkiewicz","year":"2008","unstructured":"Walkiewicz D, Werlin SL, Fish D, et al.: Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:669\u2013673.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10350-007-0225-6","volume":"50","author":"M. Scarpa","year":"2007","unstructured":"Scarpa M, D\u2019Inca R, Basso D, et al.: Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn\u2019s disease. Dis Colon Rectum 2007, 50:861\u2013869.","journal-title":"Dis Colon Rectum"},{"key":"74_CR47","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1572-0241.2008.01870.x","volume":"103","author":"R. D\u2019Inca","year":"2008","unstructured":"D\u2019Inca R, Dal Pont E, Di Leo V, et al.: Can calprotectin predict relapse risk in inflammatory bowel disease?\n                           Am J Gastroenterol 2008, 103:2007\u20132014.","journal-title":"Am J Gastroenterol"},{"key":"74_CR48","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.3748\/wjg.14.5584","volume":"14","author":"M. Wagner","year":"2008","unstructured":"Wagner M, Peterson CGB, Ridefelt P, et al.: Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008, 14:5585\u20135589.","journal-title":"World J Gastroenterol"},{"key":"74_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.6593","volume":"96","author":"C.A. Lamb","year":"2009","unstructured":"Lamb CA, Mohiuddin MK, Gicquel J, et al.: Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn\u2019s disease. Br J Surg 2009, 96:663\u2013674.","journal-title":"Br J Surg"},{"key":"74_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ajg.2008.119","volume":"104","author":"G.T. Ho","year":"2009","unstructured":"Ho GT, Lee HM, Brydon G, et al.: Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009, 104:673\u2013678.","journal-title":"Am J Gastroenterol"},{"key":"74_CR51","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1572-0241.2006.00506.x","volume":"101","author":"S.L. Triester","year":"2006","unstructured":"Triester SL, Leighton JA, Leontiadis GI, et al.: A metaanalysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn\u2019s disease. Am J Gastroenterol 2006, 101:954\u2013964.","journal-title":"Am J Gastroenterol"},{"key":"74_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/01.mcg.0000225621.02094.8a","volume":"41","author":"H.H. Fidder","year":"2007","unstructured":"Fidder HH, Nadler M, Lahat A, et al.: The utility of capsule endoscopy in the diagnosis of Crohn\u2019s disease based on patient\u2019s symptoms. J Clin Gastroenterol 2007, 41:384\u2013387.","journal-title":"J Clin Gastroenterol"},{"key":"74_CR53","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.dld.2006.02.004","volume":"38","author":"M. Bona De","year":"2006","unstructured":"De Bona M, Bellumat A, Cian E, et al.: Capsule endoscopy findings in patients with suspected Crohn\u2019s disease and biochemical markers of inflammation. Dig Liver Dis 2006, 38:331\u2013335.","journal-title":"Dig Liver Dis"},{"key":"74_CR54","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/00004836-200609000-00006","volume":"40","author":"J. Valle","year":"2006","unstructured":"Valle J, Alcantara M, Perez-Grueso MJ, et al.: Clinical features of patients with negative results from traditional diagnostic work-up and Crohn\u2019s disease findings from capsule endoscopy. J Clin Gastroenterol 2006, 40:692\u2013696.","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl","key":"74_CR55","first-page":"A351","volume":"134","author":"S. Salunke","year":"2008","unstructured":"Salunke S, Rae N, Morris AJ: Diagnostic yield of wireless capsule endoscopy in patients with elevated fecal calprotectin and normal endo-colonoscopy [abstract]. Gastroenterology 2008, 134(Suppl):A351.","journal-title":"Gastroenterology"},{"key":"74_CR56","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/ibd.20199","volume":"13","author":"L. Biancone","year":"2007","unstructured":"Biancone L, Calabrese E, Petruzziello C, et al.: Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn\u2019s disease. Inflamm Bowel Dis 2007, 13:1256\u20131265.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.gie.2008.02.017","volume":"68","author":"C.A. Solem","year":"2008","unstructured":"Solem CA, Loftus EV, Fletcher JG, et al.: Small-bowel imaging in Crohn\u2019s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008, 68:255\u2013266.","journal-title":"Gastrointest Endosc"},{"key":"74_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.gie.2008.02.037","volume":"68","author":"F. Li","year":"2008","unstructured":"Li F, Gurudu SR, De Petris G, et al.: Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures. Gastrointest Endosc 2008, 68:174\u2013180.","journal-title":"Gastrointest Endosc"},{"issue":"Suppl1","key":"74_CR59","first-page":"A100","volume":"136","author":"B.G. Levesque","year":"2009","unstructured":"Levesque BG, Cipriano SL, Chang KK, et al.: Cost-effectiveness of alternative diagnostic strategies for patients with suspected small-bowel Crohn\u2019s disease [abstract]. Gastroenterology 2009, 136(Suppl 1):A100.","journal-title":"Gastroenterology"},{"key":"74_CR60","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1055\/s-0029-1214790","volume":"41","author":"A. Bourreille","year":"2009","unstructured":"Bourreille A, Ignjatovic A, Aabakken L, et al.: Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009, 41:618\u2013637.","journal-title":"Endoscopy"},{"key":"74_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.gie.2006.05.022","volume":"64","author":"S. Mehdizadeh","year":"2006","unstructured":"Mehdizadeh S, Ross A, Gerson L, et al.: What is the learning curve associated with double-balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care centers. Gastrointest Endosc 2006, 64:740\u2013750.","journal-title":"Gastrointest Endosc"},{"key":"74_CR62","first-page":"A131","volume":"136Suppl","author":"B. Wiarda","year":"2009","unstructured":"Wiarda B, Mensik P, Heine DG, et al.: Small bowel imaging comparing MR enteroclysis, capsule endoscopy and doubleballoon enteroscopy in patients with (suspected) Crohn\u2019s disease: the COMRADE study [abstract]. Gastroenterology 2009, 136(Suppl):A131.","journal-title":"Gastroenterology"},{"key":"74_CR63","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cgh.2008.01.005","volume":"6","author":"S.F. Pasha","year":"2008","unstructured":"Pasha SF, Leighton JA, Das A, et al.: Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: a meta-analysis. Clin Gastroenterol Hepatol 2008, 6:671\u2013676.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"74_CR64","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1148\/rg.263055162","volume":"26","author":"S.R. Paulsen","year":"2006","unstructured":"Paulsen SR, Huprich JE, Fletcher JG, et al.: CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006, 26:641\u2013657.","journal-title":"Radiographics"},{"key":"74_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2214\/AJR.08.1267","volume":"192","author":"M.E. Baker","year":"2009","unstructured":"Baker ME, Walter J, Obuchowski NA, et al.: Mural attenuation in normal small bowel and active inflammatory Crohn\u2019s disease on CT enterography: location, absolute attenuation, relative attenuation, and the effect of wall thickness. AJR Am J Roentgenol 2009, 192:417\u2013423.","journal-title":"AJR Am J Roentgenol"},{"key":"74_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/radiol.2382041159","volume":"238","author":"K.D. Bodily","year":"2006","unstructured":"Bodily KD, Fletcher JG, Solem CA, et al.: Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 2006, 238:505\u2013516.","journal-title":"Radiology"},{"key":"74_CR67","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/gut.2005.084301","volume":"55","author":"J.F. Colombel","year":"2006","unstructured":"Colombel JF, Solem CA, Sandborn WJ, et al.: Quantitative measurement and visual assessment of ileal Crohn\u2019s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006, 55:1561\u20131567.","journal-title":"Gut"},{"key":"74_CR68","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2214\/AJR.07.2877","volume":"190","author":"A.K. Hara","year":"2008","unstructured":"Hara AK, Alam S, Heigh RI, et al.: Using CT enterography to monitor Crohn\u2019s disease activity: a preliminary study. AJR Am J Roentgenol 2008, 190:1512\u20131516.","journal-title":"AJR Am J Roentgenol"},{"key":"74_CR69","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/ibd.20529","volume":"14","author":"D.H. Bruining","year":"2008","unstructured":"Bruining DH, Siddiki HA, Fletcher JG, et al.: Prevalence of penetrating disease and extraintestinal manifestations of Crohn\u2019s disease detected with CT enterography. Inflamm Bowel Dis 2008, 14:1701\u20131706.","journal-title":"Inflamm Bowel Dis"},{"key":"74_CR70","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1572-0241.2008.01920.x","volume":"103","author":"J.M. Peloquin","year":"2008","unstructured":"Peloquin JM, Pardi DS, Sandborn WJ, et al.: Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008, 103:2015\u20132022.","journal-title":"Am J Gastroenterol"},{"key":"74_CR71","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/gut.2008.151415","volume":"57","author":"A.N. Desmond","year":"2008","unstructured":"Desmond AN, O\u2019Regan K, Curran C, et al.: Crohn\u2019s disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008, 57:1524\u20131529.","journal-title":"Gut"},{"key":"74_CR72","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00330-006-0248-8","volume":"16","author":"N.C. Gourtsoyiannis","year":"2006","unstructured":"Gourtsoyiannis NC, Grammatikakis J, Papamastorakis G, et al.: Imaging of small intestinal Crohn\u2019s disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol 2006, 16:1915\u20131925.","journal-title":"Eur Radiol"},{"key":"74_CR73","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00261-007-9276-3","volume":"33","author":"K. Horsthuis","year":"2008","unstructured":"Horsthuis K, Stokkers PCF, Stoker J: Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities. Abdom Imaging 2008, 33:407\u2013416.","journal-title":"Abdom Imaging"},{"key":"74_CR74","first-page":"A499","volume":"132Suppl","author":"D.S. Segarajasingam","year":"2007","unstructured":"Segarajasingam DS, Weltman C, Philpott J, et al.: Can MRI enteroclysis distinguish inflammatory changes from fibrosis in small bowel Crohn\u2019s disease? [abstract]. Gastroenterology 2007, 132(Suppl):A499.","journal-title":"Gastroenterology"},{"key":"74_CR75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00261-007-9308-z","volume":"33","author":"E.R. Ryan","year":"2008","unstructured":"Ryan ER, Heaslip ISE: Magnetic resonance enteroclysis compared with conventional enteroclysis and computed tomography enteroclysis: a critically appraised topic. Abdom Imaging 2008, 33:34\u20137.","journal-title":"Abdom Imaging"},{"key":"74_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2214\/AJR.08.2027","volume":"193","author":"H.A. Siddiki","year":"2009","unstructured":"Siddiki HA, Fidler JL, Fletcher JG, et al.: Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn\u2019s disease. AJR Am J Roentgenol 2009, 193:113\u2013121.","journal-title":"AJR Am J Roentgenol"},{"key":"74_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1148\/radiol.2471070611","volume":"247","author":"K. Horsthuis","year":"2008","unstructured":"Horsthuis K, Bipat S, Bennink RJ, et al.: Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008, 247:64\u201379.","journal-title":"Radiology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-009-0074-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0074-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:27:09Z","timestamp":1581967629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-009-0074-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,29]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s11894-009-0074-7","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,29]]}}}